ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1456

$2.22M Total Retail Price of All Prescriptions

Rank: 10 out of 1456

818 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 818 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

25% of this provider’s 818 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 15,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,012 644 S3 1 6
PRAVASTATIN SODIUM 974 679 2 9
CRESTOR 840 549 3 26
AMLODIPINE BESYLATE 768 565 4 1
LEVOTHYROXINE SODIUM 699 471 5 4
GABAPENTIN 541 340 6 13
ATORVASTATIN CALCIUM 473 353 7 11
OMEPRAZOLE 467 259 8 5
FUROSEMIDE 400 266 9 7
CARVEDILOL 370 245 10 20
JANUVIA 366 218 11 68
BENAZEPRIL HCL 349 218 12 57
RANITIDINE HCL 334 197 13 27
GLIMEPIRIDE 324 215 14 33
ALLOPURINOL 318 203 15 31
METOPROLOL TARTRATE 314 218 16 12
LISINOPRIL 312 197 17 3
CYMBALTA 303 162 18 52
CLOPIDOGREL 298 212 19 32
LOVAZA 285 121 20 162
ZOLPIDEM TARTRATE 276 136 21 14
NEXIUM 257 122 22 23
WARFARIN SODIUM 247 184 23 21
METFORMIN HCL 247 143 23 8
LOSARTAN POTASSIUM 236 178 25 16
BUPROPION XL 225 96 26 165
METFORMIN HCL ER 224 111 27 54
PLAVIX 222 157 28 46
ZETIA 216 124 29 71
FENOFIBRATE 216 133 29 56
CITALOPRAM HBR 206 125 31 22
SPIRONOLACTONE 204 114 32 73
MELOXICAM 189 110 33 30
PANTOPRAZOLE SODIUM 186 101 34 43
NOVOLOG 186 100 34 104
SIMVASTATIN 183 171 36 2
METOPROLOL SUCCINATE 181 127 37 19
SERTRALINE HCL 179 124 38 25
SPIRIVA 177 87 39 75
ISOSORBIDE MONONITRATE ER 176 77 40 60
ESCITALOPRAM OXALATE 170 110 41 74
ADVAIR DISKUS 160 73 42 63
SINGULAIR 157 91 43 83
HYDROCHLOROTHIAZIDE 155 127 44 10
JANUMET 154 122 45 176
MIRTAZAPINE 149 122 46 65
FLUOXETINE HCL 147 105 47 55
TAMSULOSIN HCL 144 116 48 34
BACLOFEN 144 60 48 168
LIDOCAINE-PRILOCAINE 143 108 50 362
ATENOLOL 142 134 51 18
CYCLOBENZAPRINE HCL 140 41 R 52 66
FLUTICASONE PROPIONATE 139 101 53 28
LEVEMIR FLEXPEN 132 83 54 207
NAMENDA 129 93 55 38
METHADONE HCL 125 73 S2 56 190
INSULIN SYRINGE 125 87 56 64
CEFUROXIME 120 80 58 138
CELEBREX 120 76 58 88
POTASSIUM CHLORIDE 117 87 60 15
WELCHOL 116 44 61 194
METOCLOPRAMIDE HCL 115 58 62 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 72 63 24
AMLODIPINE BESYLATE-BENAZEPRIL 109 108 64 61
FAMOTIDINE 109 76 64 45
RAMIPRIL 106 69 66 98
TRILIPIX 106 28 66 188
TRAMADOL HCL 105 56 68 17
PEN NEEDLE 105 74 68 131
ADVAIR HFA 102 37 70 274
TRAZODONE HCL 102 61 70 47
DONEPEZIL HCL 99 77 72 29
NIFEDIPINE ER 98 64 73 81
SYNTHROID 97 53 74 37
ENDOCET 91 62 S2 75 146
COMBIVENT 91 63 75 110
OXYCODONE HCL-ACETAMINOPHEN 90 46 S2 77 132
PREDNISONE 89 58 78 42
BENICAR 88 72 79 130
MONTELUKAST SODIUM 88 47 79 135
HYDRALAZINE HCL 88 50 79 48
HUMALOG 87 46 82 196
LYRICA 87 30 82 91
TRAMADOL HCL-ACETAMINOPHEN 86 65 84 139
TRICOR 84 42 85 92
ROPINIROLE HCL 83 40 86 90
LANTUS 81 20 87 50
QUINAPRIL HCL 80 49 88 155
LANSOPRAZOLE 77 67 89 137
ANTARA 76 68 90 447
PROAIR HFA 76 34 90 69
AGGRENOX 73 60 92 220
VENTOLIN HFA 72 18 93 121
NASONEX 71 28 94 246
AVODART 70 67 95 218
TORSEMIDE 69 46 96 145
OXYCODONE-ACETAMINOPHEN 69 21 S2 96 109
LEVEMIR 68 45 98 161
AMITRIPTYLINE HCL 67 21 R 99 70
LOSARTAN-HYDROCHLOROTHIAZIDE 65 35 100 41
DIOVAN HCT 63 47 101 59
DIOVAN 63 51 101 35
NOVOLOG FLEXPEN 62 29 103 198
SYMBICORT 62 13 103 157
NOVOLOG MIX 70-30 FLEXPEN 60 45 105 271
DIGOXIN 59 48 106 62
KLOR-CON M20 59 29 106 51
MORPHINE SULFATE ER 59 38 S2 106 173
RANEXA 59 41 106 468
TOPIRAMATE 56 0 110 196
LIPITOR 56 39 110 76
LANTUS SOLOSTAR 56 36 110 120
POLYETHYLENE GLYCOL 3350 56 20 110 85
SUCRALFATE 56 30 110 171
PRAMIPEXOLE DIHYDROCHLORIDE 54 23 115 203
BENAZEPRIL-HYDROCHLOROTHIAZIDE 54 18 115 177
CIPROFLOXACIN HCL 53 42 117 58
TRIAMTERENE-HCTZ 51 46 118 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.